197 related articles for article (PubMed ID: 32327628)
1. Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Jiang WL; Cai DB; Yin F; Zhang L; Zhao XW; He J; Ng CH; Ungvari GS; Sim K; Hu ML; Zheng W; Xiang YT
Transl Psychiatry; 2020 Apr; 10(1):117. PubMed ID: 32327628
[TBL] [Abstract][Full Text] [Related]
2. Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials.
Wu RR; Zhang FY; Gao KM; Ou JJ; Shao P; Jin H; Guo WB; Chan PK; Zhao JP
Mol Psychiatry; 2016 Nov; 21(11):1537-1544. PubMed ID: 26809842
[TBL] [Abstract][Full Text] [Related]
3. [Metformin treatment of antipsychotic-induced dyslipidemia: analysis of two randomized, placebo-controlled trials].
Yang Y; Wang X; Kang D; Long Y; Ou J; Guo W; Zhao J; Wu R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 44(10):1128-1136. PubMed ID: 31857506
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
[TBL] [Abstract][Full Text] [Related]
5. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
[TBL] [Abstract][Full Text] [Related]
6. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
[TBL] [Abstract][Full Text] [Related]
7. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
[TBL] [Abstract][Full Text] [Related]
9. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
Zheng W; Li XB; Shi ZM; Yang XH; Cai DB; Ng CH; Ungvari GS; Liu WJ; Wu YJ; Wang YY; Ning YP; Xiang YT
Pharmacopsychiatry; 2020 Jan; 53(1):5-13. PubMed ID: 31207653
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia.
Zheng W; Yang W; Zhang QE; Yang XH; Cai DB; Hu JQ; Ungvari GS; Ng CH; De Hert M; Ning YP; Xiang YT
Shanghai Arch Psychiatry; 2018 Feb; 30(1):4-11. PubMed ID: 29719353
[TBL] [Abstract][Full Text] [Related]
12. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.
Sun J; Yuan Y; Cai R; Sun H; Zhou Y; Wang P; Huang R; Xia W; Wang S
BMJ Open; 2015 Mar; 5(3):e007280. PubMed ID: 25818277
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
[TBL] [Abstract][Full Text] [Related]
15. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials.
Zheng W; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang N; Ning YP; Xiang YT
J Psychopharmacol; 2017 May; 31(5):625-631. PubMed ID: 28372526
[TBL] [Abstract][Full Text] [Related]
18. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.
de Silva VA; Suraweera C; Ratnatunga SS; Dayabandara M; Wanniarachchi N; Hanwella R
BMC Psychiatry; 2016 Oct; 16(1):341. PubMed ID: 27716110
[TBL] [Abstract][Full Text] [Related]
19. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
[TBL] [Abstract][Full Text] [Related]
20. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
